HS-RDT

DIAGNOSTIC_TEST2 trials

Sponsors

Foundation for Innovative New Diagnostics, Switzerland

Conditions

Diagnoses DiseasePlasmodium FalciparumPlasmodium Falciparum MalariaPregnancy Malaria

Unknown Phase

Clinical Performance of the HRP2 HS-RDT for Malaria Diagnosis in Pregnant Women

CompletedNCT03172221

Foundation for Innovative New Diagnostics, SwitzerlandDiagnoses Disease, Plasmodium Falciparum, Pregnancy Malaria

Start: 2017-07-25End: 2018-01-31Updated: 2023-11-30

Clinical Performance of the Histidine Rich Protein 2 (HRP2) Highly Sensitive Rapid Diagnostic Test (HS-RDT) for Malaria Diagnosis in Pregnant Women in Papua New Guinea

CompletedNCT03462615

Foundation for Innovative New Diagnostics, SwitzerlandDiagnoses Disease, Plasmodium Falciparum Malaria, Pregnancy Malaria

Start: 2018-08-15End: 2019-05-30Updated: 2026-09-17

Related Papers

Evaluation of highly sensitive diagnostic tools for the detection of P. falciparum in pregnant women attending antenatal care visits in Colombia.

2020-07-3117 citations